IRIS
MAZZANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.340
NA - Nord America 3.249
AS - Asia 2.493
SA - Sud America 354
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 107
OC - Oceania 8
Totale 11.702
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.744
US - Stati Uniti d'America 3.153
CN - Cina 1.083
SG - Singapore 578
IE - Irlanda 499
HK - Hong Kong 282
RU - Federazione Russa 255
BR - Brasile 253
VN - Vietnam 209
NL - Olanda 180
DE - Germania 139
FR - Francia 127
FI - Finlandia 120
BD - Bangladesh 86
GB - Regno Unito 73
IN - India 65
ZA - Sudafrica 57
CA - Canada 50
AR - Argentina 42
SE - Svezia 33
JP - Giappone 31
MX - Messico 30
PL - Polonia 30
UA - Ucraina 30
TR - Turchia 23
AT - Austria 18
VE - Venezuela 16
ES - Italia 15
PK - Pakistan 15
IQ - Iraq 14
MA - Marocco 14
BE - Belgio 12
CO - Colombia 12
PH - Filippine 12
ID - Indonesia 11
IR - Iran 11
EC - Ecuador 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
SA - Arabia Saudita 9
CH - Svizzera 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
BO - Bolivia 5
CL - Cile 5
GR - Grecia 5
IL - Israele 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
MD - Moldavia 4
NO - Norvegia 4
PS - Palestinian Territory 4
AL - Albania 3
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BW - Botswana 1
CG - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
Totale 11.547
Salva come PNG Salva come JPEG
Città #
Dublin 497
San Jose 381
Milan 380
Chandler 373
Ashburn 313
Hong Kong 275
Singapore 271
Beijing 264
Rome 246
Dallas 242
Naples 142
Boardman 141
Nanjing 140
Council Bluffs 114
Shanghai 92
Los Angeles 90
Lauterbourg 88
Turin 80
Helsinki 75
Princeton 74
San Genesio Ed Uniti 74
New York 72
Ho Chi Minh City 70
Jacksonville 70
Lawrence 70
Florence 63
Medford 60
Moscow 59
Wilmington 58
Bari 55
Changsha 55
Hanoi 53
Nanchang 51
Palermo 50
Johannesburg 48
Jiaxing 46
Bologna 44
Hebei 44
Shenyang 43
Redondo Beach 39
Buffalo 38
Tianjin 38
Genoa 34
Munich 34
Parma 31
Cagliari 29
Catania 29
Hangzhou 27
Brescia 26
Orem 25
Santa Clara 25
Ann Arbor 24
São Paulo 22
Montreal 21
Pavia 20
The Dalles 20
Tokyo 20
Warsaw 20
Chicago 19
Padova 19
Messina 18
Columbus 17
Pescara 17
Seattle 17
Turku 17
Verona 17
Woodbridge 17
Chennai 16
Livorno 16
Norwalk 16
Nuremberg 16
Atlanta 15
Frankfurt am Main 15
London 15
Toronto 15
San Francisco 14
Brooklyn 13
Modena 13
Phoenix 13
Pisa 13
Trieste 13
Imola 12
Taranto 12
Brussels 11
Houston 11
Monserrato 11
Reggio Emilia 11
Stockholm 11
Haiphong 10
Mexico City 10
Pomigliano d'Arco 10
Da Nang 9
Mumbai 9
Ravenna 9
Venice 9
Vienna 9
Bergamo 8
Cincinnati 8
Falls Church 8
Lahore 8
Totale 6.432
Salva come PNG Salva come JPEG
Nome #
Sindrome di Brugada e idoneità alla mansione: case report 3.852
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 191
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 148
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 143
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 136
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 134
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 133
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 128
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 126
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 125
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 124
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 120
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 120
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 118
Genetic causes of sudden cardiac death in the young. 117
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 116
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 116
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 113
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 111
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 109
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 106
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 106
Long-term follow-up of patients with short QT syndrome 106
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 105
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 101
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 96
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 95
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 94
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 92
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 92
The genetics of Long QT Syndrome 90
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 90
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 90
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 89
Brugada syndrome and job fitness: report of three cases 88
Brugada Syndrome: The Endless Conundrum 87
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 86
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 85
Usefulness of exercise test in the diagnosis of short QT syndrome 84
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 83
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 83
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 82
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 82
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 80
Brugada syndrome and job fitness: report of three cases 79
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 79
Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome 78
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 76
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 76
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 76
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 75
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome 75
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 75
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 74
Novel insights in the natural history of Short QT Syndrome 73
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 73
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 73
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 72
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 70
Genetic risk stratification in cardiac arrhythmias 70
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 70
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 70
Indications for genetic testing in athletes and its indication in clinical practice 69
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 69
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 68
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 68
Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling 67
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 66
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility 66
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 65
Dilated cardiomyopathy 65
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 65
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 62
Inherited arrhythmias: LQTS/SQTS/CPVT 62
Is there a role for genetics in the prevention of sudden cardiac death? 62
Repeat adverse events long after percutaneous coronary revascularization in diabetics 62
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 61
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 60
Diagnosis of Long QT Syndrome: Time to Stand Up! 59
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 58
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 58
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 58
Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing 57
Genetic Arrhythmias (Channelopathies) 57
Personalized therapies for cardiac channelopathies 56
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 56
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 55
Risk Stratification in the Long QT Syndrome 55
Short QT syndromes 55
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 55
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 53
The interpretation of genetic tests in inherited cardiovascular diseases 51
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 47
Induction of ventricular fibrillation during programmed ventricular stimulation in a patient with CASQ2 heterozygous mutation 29
Totale 11.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 0 7 14 0 7 13 3 19 15 24 46 173
2022/20231.174 146 92 19 69 86 101 0 54 564 3 25 15
2023/20241.841 62 86 94 175 182 257 199 168 67 177 162 212
2024/20252.950 276 188 154 197 145 229 225 262 524 168 222 360
2025/20264.091 364 239 456 430 483 148 648 219 363 329 213 199
2026/2027316 186 130 0 0 0 0 0 0 0 0 0 0
Totale 11.702